[1]Sumara I, Giménez-Abián JF, Gerlich D, et al.Rolesof polo-like kinase 1 in the assembly of functional mitoticspindles[J].Curr Biol, 2004, 14 (19) :1712-1722.
|
[2]Golsteyn RM, Mundt KE, Fry AM, et al.Cell cycle regulationof the activity and subcellular localization of Plk1, a humanprotein kinase implicated in mitotic spindle function[J].J CellBiol, 1995, 129 (6) :1617-1628.
|
[3]Zhao C, Gong L, Li W, et al.Overexpression of Plk1 promotesmalignant progress in human esophageal squamous cellcarcinoma[J].J Cancer Res Clin Oncol, 2010, 136 (1) :9-16.
|
[4]Lan B, Liu BY, Chen XH, et al.Polo like kinase 1 expressionand prognostic value in gastric carcinomas[J].ZhonghuaWeichang Waike Zazhi, 2007, 10 (1) :70-72.
|
[5]He ZL, Zheng H, Lin H, et al.Overexpression of polo-likekinase1 predicts a poor prognosis in hepatocellular carcinomapatients[J].World J Gastroenterol, 2009, 15 (33) :4177-4182.
|
[6]Takahashi T, Sano B, Nagata T, et al.Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers[J].Cancer Sci, 2003, 94 (2) :148-152.
|
[7]Zhang J, Wang S, Kern S, et al.Nitric oxide down-regulatespolo-like kinase 1 through a proximal promoter cell cycle genehomology region[J].J Biol Chem, 2007, 282 (2) :1003-1009.
|
[8]Zhu H, Chang BD, Uchiumi T, et al.Identification of promoterelements responsible for transcriptional inhibition of polo-likekinase 1 and topoisomerase IIalpha genes by p21 (WAF1/CIP1/SDI1) [J].Cell Cycle, 2002, 1 (1) :59-66.
|
[9]鲁凤民, 李雅娟, 庄辉.N-端加flag标签增加P21 (Cip1/WAF1) 蛋白质稳定性[J].癌变.畸变.突变, 2006, 18 (2) :119-121.
|
[10]Degenhardt Y, Lampkin T.Targeting Polo-like kinase incancer therapy[J].Clin Cancer Res, 2010, 16 (2) :384-389.
|
[11]Takaki T, Trenz K, Costanzo V, et al.Polo-like kinase 1 reachesbeyond mitosis--cytokinesis, DNA damage response, anddevelopment[J].Curr Opin Cell Biol, 2008, 20 (6) :650-660.
|
[12]Pellegrino R, Calvisi DF, Ladu S, et al.Oncogenic and tumorsuppressive roles of polo-like kinases in human hepatocellularcarcinoma[J].Hepatology, 2010, 51 (3) :857-868.
|
[13]Zhang MF, Zhang ZY, Fu J, et al.Correlation betweenexpression of p53, p21/WAF1, and MDM2 proteins andtheir prognostic significance in primary hepatocellularcarcinoma[J].J Transl Med, 2009, 7 (1) :110-118.
|
[14]Mitselou A, Karapiperides D, Nesseris I, et al.Alteredexpression of cell cycle and apoptotic proteins in human liverpathologies[J].Anticancer Res, 2010, 30 (11) :4493-4501.
|
[15]Park US, Park SK, Lee YI, et al.Hepatitis B virus-X proteinupregulates the expression of p21waf1/cip1 and prolongsG1-S transition via a p53-independent pathway in humanhepatoma cells[J].Oncogene, 2000, 19 (30) :3384-3394.
|
[16]Kobayashi S, Matsushita K, Saigo K, et al.P21WAF1/CIP1messenger RNA expression in hepatitis B, C virus-infectedhuman hepatocellular carcinoma tissues[J].Cancer, 2001, 91 (11) :2096-2103.
|